WebbIn Sharon Mates’ more than 25 years of leadership, she has focused on developing innovative ways to treat diseases. She is president, chief … Webb1 sep. 2024 · Lumateperone, an antipsychotic that is US Food and Drug Administration-approved for the treatment of schizophrenia, has a novel mechanism of action that may confer beneficial effects with improved tolerability. This pooled analysis of three randomized, double-blind, placebo-controlled trials was con …
BIO Board of Directors BIO
WebbFör 1 dag sedan · In accordance with its Bylaws and Articles of Incorporation, the Biotechnology Innovation Organization (BIO) is governed by its Board of Directors. The Full BIO Board of Directors is comprised of all the directors sitting on the Section Governing Boards, as described below. In addition, there is a Board Executive Committee that … Webbför 12 timmar sedan · 561. Free-Float. 96,8%. More Financials. Company. Intra-Cellular Therapies, Inc. is a biopharmaceutical company. The Company is focused on the discovery, clinical development and commercialization of small molecule drugs that address underserved medical needs primarily in neuropsychiatric and neurological … dguv rehasport antrag
Management Team Intracellular Therapies
WebbSharon Mates, Ph.D. Founder, Chairman & Chief Executive Officer Read More Suresh Durgam, M.D. Executive Vice President, Chief Medical Officer Read More Mark Neumann … Webb9 mars 2024 · Sharon Mates owns over 62,335 units of Intra-Cellular Therapies Inc stock worth over $63,410,335 and over the last 9 years he sold ITCI stock worth over … WebbJun 2024 - Present11 months. United States. I produce search-engine-optimized blog articles and treatment pages for Medstar Media's clients, and marketing material for Medstar's website ... dguv wilhelmshaven